verapamil has been researched along with hesperetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naveen Babu, K; Ravindra Babu, P; Sridhar, V; Surya Sandeep, M | 1 |
| Chu, L; Han, X; Jing, X; Li, J; Liu, M; Liu, P; Xue, Y; Zhang, M; Zhang, Y | 1 |
2 other study(ies) available for verapamil and hesperetin
| Article | Year |
|---|---|
Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using felodipine and hesperetin in combination in Wistar rats and everted rat gut sacs in vitro.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Cytochrome P-450 CYP3A; Felodipine; Half-Life; Hesperidin; Ileum; In Vitro Techniques; Intestinal Absorption; Male; Rats; Rats, Wistar; Verapamil | 2014 |
Hesperetin modulates the Sirt1/Nrf2 signaling pathway in counteracting myocardial ischemia through suppression of oxidative stress, inflammation, and apoptosis.
Topics: Animals; Antioxidants; Apoptosis; Dose-Response Relationship, Drug; Electrocardiography; Heart Function Tests; Hesperidin; Inflammation; Male; Mice; Myocardial Ischemia; Myocardium; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction; Sirtuin 1; Vasodilator Agents; Verapamil | 2021 |